Oligoadenylate-Synthetase-Family Protein OASL Inhibits Activity of the DNA Sensor cGAS during DNA Virus Infection to Limit Interferon Production.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 05 06 2018
revised: 23 10 2018
accepted: 11 12 2018
pubmed: 13 1 2019
medline: 6 7 2019
entrez: 13 1 2019
Statut: ppublish

Résumé

Interferon-inducible human oligoadenylate synthetase-like (OASL) and its mouse ortholog, Oasl2, enhance RNA-sensor RIG-I-mediated type I interferon (IFN) induction and inhibit RNA virus replication. Here, we show that OASL and Oasl2 have the opposite effect in the context of DNA virus infection. In Oasl2

Identifiants

pubmed: 30635239
pii: S1074-7613(18)30561-2
doi: 10.1016/j.immuni.2018.12.013
pmc: PMC6342484
mid: NIHMS1517018
pii:
doi:

Substances chimiques

Interferon Type I 0
Membrane Proteins 0
RNA, Small Interfering 0
Sting1 protein, mouse 0
Cyclic AMP E0399OZS9N
Nucleotidyltransferases EC 2.7.7.-
Oasl2 protein, mouse EC 2.7.7.-
cGAS protein, mouse EC 2.7.7.-
2',5'-Oligoadenylate Synthetase EC 2.7.7.84

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-63.e5

Subventions

Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118896
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA178766
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211241
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Nature. 2011 Apr 28;472(7344):481-5
pubmed: 21478870
J Immunol. 2012 Sep 1;189(5):2432-40
pubmed: 22826318
Genome Res. 2014 Oct;24(10):1719-23
pubmed: 25186908
J Interferon Cytokine Res. 2011 Jan;31(1):41-7
pubmed: 21142819
J Med Virol. 2016 May;88(5):760-8
pubmed: 26437676
PLoS Med. 2007 Dec;4(12):e353
pubmed: 18162040
Immunity. 2014 Mar 20;40(3):329-41
pubmed: 24560620
Annu Rev Immunol. 2017 Apr 26;35:313-336
pubmed: 28142323
J Virol. 2011 Jan;85(1):21-31
pubmed: 20962097
J Virol. 2015 Oct;89(19):10115-9
pubmed: 26178980
Nat Immunol. 2016 Apr;17(4):369-78
pubmed: 26829768
Nat Rev Immunol. 2015 Jul;15(7):429-40
pubmed: 26052098
Clin Rheumatol. 2007 Feb;26(2):186-90
pubmed: 16565890
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4612-E4620
pubmed: 28533362
Nature. 2013 Jun 20;498(7454):332-7
pubmed: 23722159
J Exp Med. 2004 Aug 16;200(4):527-33
pubmed: 15302899
Elife. 2016 May 31;5:
pubmed: 27240734
Nat Rev Immunol. 2014 Aug;14(8):521-8
pubmed: 25033909
J Virol. 1998 Apr;72(4):3307-20
pubmed: 9525658
Methods Biochem Anal. 2005;46:1-265
pubmed: 16350889
Methods Mol Biol. 2016;1338:261-72
pubmed: 26443227
Nat Struct Mol Biol. 2014 Feb;21(2):167-74
pubmed: 24413054
Cell Rep. 2013 May 30;3(5):1355-61
pubmed: 23707065
Nature. 2014 Jul 3;511(7507):99-103
pubmed: 24990750
Nature. 2017 Aug 24;548(7668):461-465
pubmed: 28738408
Nature. 2017 Sep 21;549(7672):394-398
pubmed: 28902841
J Virol. 2017 Jun 26;91(14):
pubmed: 28446670
Nature. 2017 Aug 24;548(7668):466-470
pubmed: 28759889
Science. 2010 Jun 25;328(5986):1703-5
pubmed: 20508090
Immunity. 2014 Jun 19;40(6):936-48
pubmed: 24931123
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2241-6
pubmed: 26858407
Cell. 2013 May 23;153(5):1094-107
pubmed: 23647843
J Gene Med. 1999 Nov-Dec;1(6):400-6
pubmed: 10753065
Nature. 2014 Jan 30;505(7485):691-5
pubmed: 24284630
Nat Cell Biol. 2017 Sep;19(9):1061-1070
pubmed: 28759028
Cell. 2013 Oct 24;155(3):688-98
pubmed: 24119841
Sci Rep. 2016 Jan 11;6:19089
pubmed: 26750802
J Virol. 2014 Jul;88(14):7738-52
pubmed: 24760893
Cell Host Microbe. 2014 Feb 12;15(2):228-38
pubmed: 24528868
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Nat Immunol. 2016 Sep 20;17(10):1142-9
pubmed: 27648547
J Virol. 2015 Mar;89(5):2731-8
pubmed: 25540366
Exp Mol Med. 2015 Mar 06;47:e144
pubmed: 25744296
Immunity. 2013 Dec 12;39(6):1019-31
pubmed: 24332030
Nat Immunol. 2013 Apr;14(4):346-55
pubmed: 23416614
Nature. 2013 Nov 28;503(7477):530-4
pubmed: 24077100
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Front Immunol. 2017 Aug 23;8:1006
pubmed: 28878774
J Immunol. 2013 Mar 1;190(5):2311-9
pubmed: 23345332
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4239-44
pubmed: 22371602
PLoS Pathog. 2014 Mar 27;10(3):e1003999
pubmed: 24675692
Science. 2018 Aug 17;361(6403):704-709
pubmed: 29976794
Adv Immunol. 2017;133:121-169
pubmed: 28215278
Cell Host Microbe. 2016 Apr 13;19(4):515-528
pubmed: 27078069
Mol Cell. 2015 Sep 17;59(6):891-903
pubmed: 26300263
Science. 2013 Sep 20;341(6152):1390-4
pubmed: 23989956
Immunity. 2018 Sep 18;49(3):413-426.e5
pubmed: 30170814
Cell Host Microbe. 2015 Jun 10;17(6):820-8
pubmed: 26048137
Cell Syst. 2018 Dec 26;7(6):627-642.e6
pubmed: 30471916
Nature. 2017 Oct 19;550(7676):402-406
pubmed: 28976970
Nat Struct Mol Biol. 2017 Dec;24(12):1124-1131
pubmed: 29106411
Immunity. 2016 Sep 20;45(3):555-569
pubmed: 27637147
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Nat Rev Rheumatol. 2016 Aug;12(8):439-40
pubmed: 27411904

Auteurs

Arundhati Ghosh (A)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Lulu Shao (L)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Padmavathi Sampath (P)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

Baoyu Zhao (B)

Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.

Nidhi V Patel (NV)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.

Jianzhong Zhu (J)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Bharat Behl (B)

Department of Immunology, University of Connecticut Health School of Medicine, Farmington, CT 06030, USA.

Robert A Parise (RA)

Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15213, USA.

Jan H Beumer (JH)

Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15213, USA.

Roderick J O'Sullivan (RJ)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Neal A DeLuca (NA)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Stephen H Thorne (SH)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

Vijay A K Rathinam (VAK)

Department of Immunology, University of Connecticut Health School of Medicine, Farmington, CT 06030, USA.

Pingwei Li (P)

Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.

Saumendra N Sarkar (SN)

Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA. Electronic address: saumen@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH